Company
Every investor coverage indicates participated in a round Helaina raised.
Companies Helaina acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Helaina. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Interview with Eclipse Ingredients' chief executive on commercialising human lactoferrin through precision fermentation, beginning with cosmetics, plus its distributor agreements and partnerships for manufacturing scale-up.
Australian food-tech firm All G has launched a low-iron, fermentation-derived lactoferrin in the US, producing multiple tonnes yearly via a Chinese manufacturer, with European capacity and a human-equivalent version planned.
Precision fermentation startup All G banked A$10 million through a convertible note and teamed up with French dairy ingredients maker Armor Protéines to sell lactoferrin, targeting a first product launch in early 2026.